News
Covid-19: infection-vaccination combination best protects against reinfection with SARS-CoV-2
Several CIRI teams carried out this work, published in the journal Science Translational Medicine.
Publications 2021
Découvrez le CIRI à travers une sélection de ses publications de l'année 2021
Web Conférence Grand Public
La Société Francaise de Virologie vous invite à une Web Conférence Grand Public présentée par Dr. Hubert Laude
Séminaire CIRI: Dr. Suzana Salcedo
Dr. Suzana Salcedo (IBCP Lyon; MMSB): "Studying nosocomial bacterial pathogenesis: old toxins, new functions"
Le CIRI au 23ème ANRS | EID AC42
Le CIRI est représenté, ces mardi 23 et mercredi 24 mai 2023, au meeting du Réseau National des Hépatites virales qui se déroule à Paris.
Inauguration of the Rosalind Franklin building
The new Rosalind Franklin building was inaugurated on October 25, in the presence of sponsors and managing bodies representatives, journalists and CIRI and SFR staff. Here's a look back at the day's events.
Sidaction donors discover CIRI with the LP2L team
On October 12, 2023, Sidaction donors visited the laboratory of the LP2L team (A. Cimarelli, L. Etienne). Here's a look back at this successful moment of sharing.
2023 PEPR MIE recipients : CIRI involved in 6 projects
Among the 11 laureates of the PEPR MIE 2023 call for projects (ANRS|Emerging Infectious Diseases), 6 projects involve CIRI teams. Their common aim is to better understand, prevent and control the emergence or re-emergence of infectious diseases.
Launch of the Chaire industrielle REVIDA
On october 11, the Chaire industrielle REVIDA about respiratory infectious diseases, led by the researcher Sophie Trouillet-Assant (UCBL/HCL), was officially launched by the Université Claude Bernard Lyon 1, the Hospices Civils de Lyon, and bioMérieux, with the support of the Agence nationale de la recherche. It should enable the improvement of the capacity of health systems to face the emerging of new respiratory diseases.
Demain, mais en mieux !
Meet with Cyrille Mathieu at the Yggdrasil festival, to learn all about viruses!
VirPath team wins two awards of research and innovation
The VirPath team was awarded two times during the 2023 research and innovation awards ceremony of the Université Claude Bernard Lyon 1. We look back at these awards and on the research program of the International Associate Laboratory RESPIVIR France-Canada.
"Têtes chercheuses": research in cancerology, presented by the fondation ARC
The ARC Foundation brings together 5 leading cancer researchers for a 45-minute program. It will give the floor to experienced researchers and young talents, all ready to take up, together, the challenges of curing more patients.
The CIRI recruits a Junior Professor (Inserm Chair)-Bacterial Immunity, phagotherapy and new therapies to combat antibiotic resistance.
The Inserm chair recruitments opened to Inserm are intended for researchers with strong potential to manage and lead research teams and participate in national, European or international projects. This recruitment, based on research and teaching projects, is aimed at researchers with a doctorate or equivalent and a first post-doctoral experience. The position is offered on a fixed-term contract (CDD) with a view to tenure in the Inserm Research Directors personnel at the end of the contract.
Rare Disease Day 2024
February 29, 2024 is Rare Disease Day. This is an opportunity to thank the clinicians and researchers who are advancing research on this subject at CIRI, as well as our patients!
Kick-off of the industrial chair VIRESP
On Wednesday January 24, 2024, Université Claude Bernard Lyon 1 (UCBL), Hospices Civils de Lyon (HCL) (HCL), the French National Research Agency (ANR) and Sanofi officially launched the the VIRESP industrial chair, a research project focusing on the development of techniques and tools for analyzing the risk of infection and the morbidity rate of diseases in different populations, but also to determine the benefits of vaccination programs.
The LIA RESPIVIR was honored during the meeting of the French and Quebec Prime Ministers
The RESPIVIR France - Canada International Research Laboratory was very well received at the 21st alternating meeting between the Quebec and French prime ministers, François Legault and Gabriel Attal, which took place in Quebec from April 10 to 12.
David Durantel is the new President Elect of the International Society for Antiviral Research
David Durantel (HepVir team and virology specialty coordinator) was elected President Elect of the ISAR (International Society for Antiviral Research), thus strenghtening the role of CIRI researchers in the international area of virology and antiviral research!